A platform to manage opioid dispensing and disposal for patients leaving the emergency department
Integration of an opioid dispensing, monitoring, and disposal platform with a hospital pharmacy to reduce opioid use by discharged emergency department patients
This study is working on a new way to help patients who leave the emergency room by making sure they get the right opioid prescriptions and support, so they can use their medications safely and reduce the chances of misuse.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Addinex Technologies, INC. NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11246982 on NIH RePORTER |
What this research studies
This research aims to integrate a system that monitors and manages opioid prescriptions for patients discharged from the emergency department. By collaborating with hospital pharmacies, the project seeks to reduce opioid use through effective dispensing and safe disposal methods. Patients will benefit from a streamlined process that ensures they receive the right medications while minimizing the risk of misuse. The approach includes monitoring patient intake and providing follow-up support to ensure compliance and safety.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients who have been prescribed opioids upon discharge from the emergency department.
Not a fit: Patients who do not receive opioid prescriptions or those who are not discharged from the emergency department may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce opioid misuse among patients discharged from emergency departments.
How similar studies have performed: Other research has shown success in similar approaches to managing opioid prescriptions and reducing misuse, indicating potential for positive outcomes.
Where this research is happening
New York, United States
- Addinex Technologies, INC. — New York, United States (Active)
Researchers
- Principal investigator: Roslyakov, Stanislav — Addinex Technologies, INC.
- Study coordinator: Roslyakov, Stanislav
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.